PT-141
Bremelanotide
SEXUAL HEALTH
$459 - 10 mg/ml - 2 ml vial
10 injection doses per mouth per vial
In Stock
The Benefits of PT-141
-
Targets specific receptors that control sexual function
-
Maximizes blood flow
-
Heightens experience and satisfaction
-
Increases natural lubrication
-
Increases connection and intimacy
-
Enhances sensitivity
DOSAGE / FREQUENCY
Dosage and Frequency
1.75mg (0.2ml) injected subcutaneously at least 45 minutes before a sexual activity. Do not use more than one dose of this medicine within 24 hours. Do not use more than 8 doses per month.
IMPORTANT!
Bremelanotide is contraindicated in patients who have uncontrolled hypertension or known cardiac disease.
PT-141 BENEFITS: MEN
In men, PT-141 improves erectile function and promotes sexual desire. Unlike oral ED medications that increase blood flow into the penis, PT-141 works in the brain to increase sexual desire. In a double-blind placebo-controlled study, approximately 80% of men developed an erection satisfactory for intercourse after using PT-141, whether the cause of ED was physical or psychological, and 68% of men reported an increase in sexual desire.2 PT-141 has shown effectiveness in treating ED in men with diabetes or who do not respond to sildenafil.
PT-141 BENEFITS: WOMEN
PT-141 has been studied and FDA-approved in women for its potential use in treating HSDD in premenopausal women. HSDD is characterized by a persistent lack of sexual desire that causes distress.
Based on DSM-5 criteria, HSDD can be diagnosed when women notice a decrease in three or more of the following and are distressed by these symptoms:
-
Sexual or erotic fantasies or thoughts
-
Interest or arousal in response to erotic stimuli, whether internal or external
-
Interest in sexual activity
-
Pleasure or excitement during sexual activity
-
Genital or non-genital sensations
-
Initiating sexual activity or responding when a partner initiates sexual activity